Pharmaceutical industry news
Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.
33,661 stories, page 22 of 562
🇺🇸Researchclinicaltrials.gov
NCT06820463: A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Study type: INTERVENTIONAL. Phase: PHASE2.
ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.gov
NCT06065748: A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Study type: INTERVENTIONAL. Phase: PHASE3.
ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.gov
NCT05642195: Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.
ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.gov
NCT04751409: Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities
Study type: INTERVENTIONAL. Phase: PHASE2.
ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.gov
NCT04543617: A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
Study type: INTERVENTIONAL. Phase: PHASE3.
ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.gov
NCT03137511: Optimizing Access to Care Through New Technologies: a Randomized Study Evaluating the Impact of Telephone Contact and the Sending by the General Practitioner of Suspicious Lesions Melanoma Photographs Taken With a Smartphone, on the Time Limit to the Consultation With a Dermatologist
Study type: INTERVENTIONAL. Phase: NA.
ClinicalTrials.govOriginal source






